| |
| |
|
| Insider
Information: |
Babu Yarlagadda S |
| Relationship: |
Chief Discovery Officer |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
298,541 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,337,464 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
298,541 |
|
|
| Total
Value |
$1,337,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -66.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Discovery Officer |
2022-11-14 |
298,541 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2022-11-14 |
4 |
S |
$13.88 |
$437,428 |
D/D |
(31,515) |
298,541 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2022-11-14 |
4 |
OE |
$1.42 |
$142,000 |
D/D |
100,000 |
330,056 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2022-03-07 |
4 |
S |
$17.16 |
$343,200 |
D/D |
(20,000) |
230,056 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
250,056 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2021-12-07 |
4 |
S |
$12.20 |
$367,220 |
D/D |
(30,100) |
215,056 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2021-12-07 |
4 |
OE |
$4.73 |
$293,260 |
D/D |
62,000 |
245,156 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2021-02-19 |
4 |
OE |
$4.15 |
$207,500 |
D/D |
50,000 |
205,587 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2021-02-19 |
4 |
D |
$11.53 |
$258,629 |
D/D |
(22,431) |
183,156 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2019-11-18 |
4 |
B |
$1.45 |
$36,250 |
D/D |
25,000 |
155,587 |
2.74 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2019-01-31 |
4 |
D |
$8.68 |
$81,479 |
D/D |
(9,387) |
130,587 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2019-01-31 |
4 |
OE |
$1.20 |
$38,249 |
D/D |
31,874 |
132,272 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2019-01-01 |
4 |
D |
$8.07 |
$6,222 |
D/D |
(771) |
108,100 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2018-03-06 |
4 |
D |
$5.18 |
$109,428 |
D/D |
(21,125) |
108,871 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2018-03-06 |
4 |
OE |
$3.26 |
$97,800 |
D/D |
30,000 |
114,773 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2018-01-20 |
4 |
D |
$5.59 |
$21,644 |
D/D |
(3,872) |
99,996 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2018-01-01 |
4 |
D |
$4.91 |
$4,115 |
D/D |
(838) |
103,868 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2017-01-20 |
4 |
D |
$5.95 |
$30,244 |
D/D |
(5,083) |
104,706 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$10,375 |
D/D |
(1,639) |
109,789 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-08-25 |
4 |
S |
$4.06 |
$121,800 |
D/D |
(30,000) |
111,428 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$1,930 |
D/D |
(906) |
141,428 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-01-20 |
4 |
D |
$7.55 |
$35,666 |
D/D |
(4,724) |
142,334 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$16,914 |
D/D |
(1,639) |
147,058 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-03-19 |
4 |
S |
$10.16 |
$122,987 |
D/D |
(12,105) |
148,697 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-03-05 |
4 |
S |
$10.59 |
$396,066 |
D/D |
(37,400) |
160,802 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-03-04 |
4 |
S |
$10.50 |
$110,198 |
D/D |
(10,495) |
198,202 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
